These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24558408)

  • 21. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity during pregnancy affects sex steroid concentrations depending on fetal gender.
    Maliqueo M; Cruz G; Espina C; Contreras I; García M; Echiburú B; Crisosto N
    Int J Obes (Lond); 2017 Nov; 41(11):1636-1645. PubMed ID: 28676682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and comparative analyses of myocardial miRNAs involved in the fetal response to maternal obesity.
    Maloyan A; Muralimanoharan S; Huffman S; Cox LA; Nathanielsz PW; Myatt L; Nijland MJ
    Physiol Genomics; 2013 Oct; 45(19):889-900. PubMed ID: 23922128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association between amniotic fluid insulin in the second trimester, maternal glucose tolerance and fetal malformations].
    Bühling KJ; Mönnich J; Henrich W; Brauer M; Heinze T; Siebert G; Dudenhausen JW
    Z Geburtshilfe Neonatol; 2004 Dec; 208(6):226-31. PubMed ID: 15647986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenic increase in N-3/n-6 Fatty Acid ratio reduces maternal obesity-associated inflammation and limits adverse developmental programming in mice.
    Heerwagen MJ; Stewart MS; de la Houssaye BA; Janssen RC; Friedman JE
    PLoS One; 2013; 8(6):e67791. PubMed ID: 23825686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the concentrations of interleukin 15 in amniotic fluid in the second and the third trimesters of pregnancy.
    Klimkiewicz-Blok D; Florjański J; Zalewski J; Blok R
    Adv Clin Exp Med; 2012; 21(1):75-9. PubMed ID: 23214303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal obesity upregulates fatty acid and glucose transporters and increases expression of enzymes mediating fatty acid biosynthesis in fetal adipose tissue depots.
    Long NM; Rule DC; Zhu MJ; Nathanielsz PW; Ford SP
    J Anim Sci; 2012 Jul; 90(7):2201-10. PubMed ID: 22266999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Switching obese mothers to a healthy diet improves fetal hypoxemia, hepatic metabolites, and lipotoxicity in non-human primates.
    Wesolowski SR; Mulligan CM; Janssen RC; Baker PR; Bergman BC; D'Alessandro A; Nemkov T; Maclean KN; Jiang H; Dean TA; Takahashi DL; Kievit P; McCurdy CE; Aagaard KM; Friedman JE
    Mol Metab; 2018 Dec; 18():25-41. PubMed ID: 30337225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
    Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The amniotic fluid transcriptome: a source of novel information about human fetal development.
    Hui L; Slonim DK; Wick HC; Johnson KL; Bianchi DW
    Obstet Gynecol; 2012 Jan; 119(1):111-8. PubMed ID: 22183218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exercise prevents the adverse effects of maternal obesity on placental vascularization and fetal growth.
    Son JS; Liu X; Tian Q; Zhao L; Chen Y; Hu Y; Chae SA; de Avila JM; Zhu MJ; Du M
    J Physiol; 2019 Jul; 597(13):3333-3347. PubMed ID: 31115053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second-trimester amniotic fluid corticotropin-releasing hormone and urocortin in relation to maternal stress and fetal growth in human pregnancy.
    La Marca-Ghaemmaghami P; Dainese SM; Stalla G; Haller M; Zimmermann R; Ehlert U
    Stress; 2017 May; 20(3):231-240. PubMed ID: 28347187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal obesity programs mitochondrial and lipid metabolism gene expression in infant umbilical vein endothelial cells.
    Costa SM; Isganaitis E; Matthews TJ; Hughes K; Daher G; Dreyfuss JM; da Silva GA; Patti ME
    Int J Obes (Lond); 2016 Nov; 40(11):1627-1634. PubMed ID: 27531045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indication-specific accuracy of second-trimester genetic ultrasonography for the detection of trisomy 21.
    Vintzileos AM; Guzman ER; Smulian JC; Day-Salvatore DL; Knuppel RA
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1045-8. PubMed ID: 10561615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amniocentesis and chorionic villus sampling for prenatal diagnosis.
    Alfirevic Z; Navaratnam K; Mujezinovic F
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD003252. PubMed ID: 28869276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second trimester maternal plasma and amniotic fluid adipokines in women who will develop gestational diabetes mellitus.
    Fruscalzo A; Londero AP; Biasizzo J; Curcio F; Bertozzi S; Marchesoni D; Driul L
    Gynecol Endocrinol; 2015; 31(12):934-8. PubMed ID: 26369835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second trimester amniotic fluid annexin A5 levels and subsequent development of intrauterine growth restriction.
    Dundar O; Yoruk P; Tutuncu L; Muhcu M; Ipcioglu O; Ergur AR; Mungen E
    Prenat Diagn; 2008 Oct; 28(10):887-91. PubMed ID: 18792921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis.
    Leruez-Ville M; Stirnemann J; Sellier Y; Guilleminot T; Dejean A; Magny JF; Couderc S; Jacquemard F; Ville Y
    Am J Obstet Gynecol; 2016 Sep; 215(3):342.e1-9. PubMed ID: 27063062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.